Jay Mei at BIIS 2018 (Endpoints/PharmCube)
Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms
Jay Mei remembers the exact date he first met BeiGene CEO John Oyler.
It was May 14, 2016, and Mei — then an executive director of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
